BR9913652A - Gene e proteìna antigênica imunodominante de 120 kda de ehrlichia canis - Google Patents
Gene e proteìna antigênica imunodominante de 120 kda de ehrlichia canisInfo
- Publication number
- BR9913652A BR9913652A BR9913652-0A BR9913652A BR9913652A BR 9913652 A BR9913652 A BR 9913652A BR 9913652 A BR9913652 A BR 9913652A BR 9913652 A BR9913652 A BR 9913652A
- Authority
- BR
- Brazil
- Prior art keywords
- protein
- ehrlichia canis
- kda
- canis
- gene
- Prior art date
Links
- 241000605312 Ehrlichia canis Species 0.000 title abstract 5
- 229940051998 ehrlichia canis Drugs 0.000 title abstract 4
- 230000000890 antigenic effect Effects 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 101710173353 Cytotoxicity-associated immunodominant antigen Proteins 0.000 abstract 4
- 241000282465 Canis Species 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 abstract 1
- 241000605310 Ehrlichia chaffeensis Species 0.000 abstract 1
- 206010020429 Human ehrlichiosis Diseases 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 208000000292 ehrlichiosis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Materials For Medical Uses (AREA)
Abstract
Patente de Invenção: <B>"GENE E PROTEìNA ANTIGêNICA IMUNODOMINANTE DE 120 KDA DE EHRLICHIA CANIS"<D>. A presente invenção provê um gene de proteína de 120 kDa de Ehrlichia canis, ampliado por PCR usando-se iniciadores derivados das seq³ências de DNA que flanqueiam o gene de proteína de 120 kDa de Ehrlichia chaffeensis. A proteína de 120 kDa de Ehrlichia canis recombinante contém 14 unidades de repetição tandem com 36 aminoácidos cada. As unidades de repetição são hidrofílicas e são preditas ser de superfície exposta. Também revelado é que a proteína de 120 kDa de E. canis recombinante é antigênica e reage com soros oriundos de cachorros convalescentes de erliquiose canina.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/141,047 US6043085A (en) | 1998-08-27 | 1998-08-27 | Ehrlichia canis 120-kDa immunodominant antigenic protein and gene |
US09/141,047 | 1998-08-27 | ||
PCT/US1999/019538 WO2000012688A1 (en) | 1998-08-27 | 1999-08-27 | Ehrlichia canis 120-kda immunodominant antigenic protein and gene |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9913652A true BR9913652A (pt) | 2001-06-05 |
BR9913652B1 BR9913652B1 (pt) | 2014-02-18 |
Family
ID=22493934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9913652-0A BR9913652B1 (pt) | 1998-08-27 | 1999-08-27 | Vetor compreendendo sequência de Ehrlichia canis, bem como microoganismo transgênico |
Country Status (17)
Country | Link |
---|---|
US (1) | US6043085A (pt) |
EP (1) | EP1108014B1 (pt) |
JP (1) | JP4550998B2 (pt) |
KR (1) | KR100652469B1 (pt) |
CN (1) | CN1281747C (pt) |
AT (1) | ATE328073T1 (pt) |
AU (1) | AU764853B2 (pt) |
BR (1) | BR9913652B1 (pt) |
CA (1) | CA2340462A1 (pt) |
DE (1) | DE69931639D1 (pt) |
IL (2) | IL141613A0 (pt) |
MX (1) | MXPA01002042A (pt) |
NZ (1) | NZ510103A (pt) |
RU (1) | RU2232814C2 (pt) |
TW (1) | TW557326B (pt) |
WO (1) | WO2000012688A1 (pt) |
ZA (1) | ZA200101440B (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6392023B1 (en) * | 1999-03-03 | 2002-05-21 | Research Development Foundation | Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof |
US20020115840A1 (en) * | 1998-11-30 | 2002-08-22 | Walker David H. | Homologous 28-kilodaltion immunodominant protein genes of Ehrlichia canis and uses thereof |
US7335754B2 (en) | 1999-07-21 | 2008-02-26 | Cornell Research Foundation, Inc. | Ehrlichia canis genes and vaccines |
US6355777B1 (en) * | 2000-04-28 | 2002-03-12 | Research Development Foundation | P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof |
AU2001259304A1 (en) * | 2000-05-01 | 2001-11-12 | Research Development Foundation | Ehrlichia chaffeensis 28 kda outer membrane protein multigene family |
MXPA05004804A (es) * | 2002-11-04 | 2005-12-05 | Res Dev Foundation | Antigenos de p153 y p156 para el inmunodiagnostico de erliquiosis canina y humana y usos de los mismos. |
US20050202046A1 (en) * | 2004-03-11 | 2005-09-15 | Wyeth | Canine vaccine for protection against ehrlichiosis |
EP1879914B1 (en) | 2005-04-04 | 2015-07-15 | Idexx Laboratories, Inc. | Ehrlichia canis diva (differentiate infected from vaccinated animals) antigens |
US7842474B2 (en) | 2005-04-04 | 2010-11-30 | Idexx Laboratories, Inc. | Ehrlichia canis DIVA (differentiate infected from vaccinated animals) |
WO2009034575A1 (en) | 2007-09-11 | 2009-03-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Attenuated ehrlichiosis vaccine |
CA2700474C (en) * | 2007-09-21 | 2016-10-04 | Idexx Laboratories, Inc. | Methods and compositions for detection of ehrlichia chaffeensis (p120) |
CN101970463A (zh) * | 2007-09-21 | 2011-02-09 | 艾德克斯实验室公司 | 用于检测恰菲埃里希氏体(vlpt)的方法和组合物 |
EP2045816A1 (en) * | 2007-10-01 | 2009-04-08 | Paul Scherrer Institut | Fast readout method and swiched capacitor array circuitry for waveform digitizing |
CZ2007716A3 (cs) | 2007-10-15 | 2009-04-29 | Elmarco S. R. O. | Zpusob výroby nanovláken |
KR101621038B1 (ko) * | 2007-10-31 | 2016-05-16 | 아이덱스 래보러토리즈, 인코포레이티드 | 에를리히아 카니스 diva(감염된 동물을 백신접종된 동물과 구별) |
KR101010432B1 (ko) * | 2008-08-30 | 2011-01-21 | 이영수 | 여과기 |
EP2424880B1 (en) * | 2009-04-28 | 2016-07-20 | Research Development Foundation | Immunoreactive ehrlichia p120/p140 epitopes and uses thereof |
CN105203755B (zh) * | 2009-11-20 | 2018-01-05 | 爱贝斯股份有限公司 | 用于检测埃里希体属抗体的肽、装置和方法 |
BR112012033751B1 (pt) * | 2010-07-02 | 2021-06-01 | Intervet International B.V. | Composição de vacina e processo para produzir a composição de vacina |
JP6325553B2 (ja) | 2012-10-11 | 2018-05-16 | アバクシス, インコーポレイテッド | エールリヒア抗体の検出のためのペプチド、デバイス、および方法 |
US9442112B2 (en) | 2014-04-04 | 2016-09-13 | Abaxis, Inc. | Compositions and methods for identifying Ehrlichia species |
WO2020023950A1 (en) * | 2018-07-27 | 2020-01-30 | Research Development Foundation | Chimeric immunogenic polypeptides |
WO2021011456A1 (en) * | 2019-07-12 | 2021-01-21 | Research Development Foundation | Ehrlichia vaccines and immunogenic compositions |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6015691A (en) * | 1996-05-31 | 2000-01-18 | Research Development Foundation | Immunodominant 120 kDa surface-exposed adhesion protein genes of Ehrlichia chaffeensis |
-
1998
- 1998-08-27 US US09/141,047 patent/US6043085A/en not_active Expired - Lifetime
-
1999
- 1999-08-27 IL IL14161399A patent/IL141613A0/xx unknown
- 1999-08-27 DE DE69931639T patent/DE69931639D1/de not_active Expired - Lifetime
- 1999-08-27 AU AU55864/99A patent/AU764853B2/en not_active Ceased
- 1999-08-27 RU RU2001107969/13A patent/RU2232814C2/ru not_active IP Right Cessation
- 1999-08-27 BR BRPI9913652-0A patent/BR9913652B1/pt not_active IP Right Cessation
- 1999-08-27 WO PCT/US1999/019538 patent/WO2000012688A1/en active IP Right Grant
- 1999-08-27 EP EP99942504A patent/EP1108014B1/en not_active Expired - Lifetime
- 1999-08-27 NZ NZ510103A patent/NZ510103A/en not_active IP Right Cessation
- 1999-08-27 KR KR1020017002453A patent/KR100652469B1/ko not_active IP Right Cessation
- 1999-08-27 CN CNB998116637A patent/CN1281747C/zh not_active Expired - Fee Related
- 1999-08-27 AT AT99942504T patent/ATE328073T1/de not_active IP Right Cessation
- 1999-08-27 JP JP2000567675A patent/JP4550998B2/ja not_active Expired - Fee Related
- 1999-08-27 MX MXPA01002042A patent/MXPA01002042A/es not_active IP Right Cessation
- 1999-08-27 CA CA002340462A patent/CA2340462A1/en not_active Abandoned
- 1999-11-25 TW TW088120623A patent/TW557326B/zh not_active IP Right Cessation
-
2001
- 2001-02-21 ZA ZA200101440A patent/ZA200101440B/xx unknown
- 2001-02-23 IL IL141613A patent/IL141613A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR100652469B1 (ko) | 2006-12-01 |
MXPA01002042A (es) | 2002-06-21 |
EP1108014B1 (en) | 2006-05-31 |
US6043085A (en) | 2000-03-28 |
EP1108014A4 (en) | 2004-12-15 |
IL141613A (en) | 2010-05-31 |
CN1321190A (zh) | 2001-11-07 |
NZ510103A (en) | 2004-10-29 |
ATE328073T1 (de) | 2006-06-15 |
AU764853B2 (en) | 2003-09-04 |
WO2000012688A1 (en) | 2000-03-09 |
DE69931639D1 (en) | 2006-07-06 |
TW557326B (en) | 2003-10-11 |
BR9913652B1 (pt) | 2014-02-18 |
EP1108014A1 (en) | 2001-06-20 |
JP2002523087A (ja) | 2002-07-30 |
KR20010072997A (ko) | 2001-07-31 |
AU5586499A (en) | 2000-03-21 |
IL141613A0 (en) | 2002-03-10 |
RU2232814C2 (ru) | 2004-07-20 |
JP4550998B2 (ja) | 2010-09-22 |
CN1281747C (zh) | 2006-10-25 |
CA2340462A1 (en) | 2000-03-09 |
ZA200101440B (en) | 2002-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9913652A (pt) | Gene e proteìna antigênica imunodominante de 120 kda de ehrlichia canis | |
RU2431671C2 (ru) | Химерные, гибридные и тандемные полипептиды менингококкового белка nmb1870 | |
CO5700785A2 (es) | Composiciones inmunogenicas novedosas para la prevencion y el tratamiento de enfermedad meningococal | |
DE60335350D1 (de) | Adjuvantien für dns impstoffe basierend auf imidazochinoline | |
PT783321E (pt) | Sequencia nucleotidica viral vr-2332 e metodos de utilizacao | |
BR122016004546B8 (pt) | vírus adenoassociado recombinante, método de geração do referido vírus e composição compreendendo o referido vírus | |
BRPI0211191B8 (pt) | ensaios baseados em ácido nucléico para se diagnosticar precisamente infecção por parvovírus b19 e inciadores e marcadores para uso nesses ensaios | |
DE69836588D1 (de) | Tuberkulose impfstoff | |
BRPI0407207A (pt) | Método para tratar, prevenir e diagnosticar uma infecção por heliocobacter | |
ATE348881T1 (de) | Thermostabiles taq polymerase fragment | |
ATE541944T1 (de) | Polynukleotidprimer | |
BRPI0409789A (pt) | vacina de tuberculose com eficácia aperfeiçoada | |
PT1219711E (pt) | Vacina de lawsonia intracellularis | |
WO2006116763A3 (en) | Lawsonia intracellularis immunological proteins | |
PE20061441A1 (es) | Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia | |
ATE447612T1 (de) | Fluoreszenzproteine | |
ATE543513T1 (de) | Anti-coronavirus impfstoff | |
EP1602721A4 (en) | PHOSPHOLIPASE A SB 2 / SB ORIGIN MOLD KOJI | |
DE60235027D1 (de) | Sperm faktoren sequenzen | |
CY1106337T1 (el) | Μια ακολουθια dna του ενζυμου φωσφολιπαση α1 απο ciliate tetrahymena και η χρησιμοποιηση του | |
FR2724385B1 (fr) | Vaccin de la peritonite infectieuse feline. | |
ATE344802T1 (de) | Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure | |
WO2003054181A3 (en) | Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants | |
BR9811501A (pt) | Sequência de nucleotìdeos do gene nucleocapsìdeo de vìrus oropouche | |
RU2006133681A (ru) | Гибридный белок сурфактант-интерферон для медицинского применения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/02/2014, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time | ||
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2476 DE 19-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |